Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
Cerilliant
QuintilesIMS
Medtronic
Healthtrust
Cipla
Chinese Patent Office
Merck
Federal Trade Commission

Generated: February 21, 2018

DrugPatentWatch Database Preview

Claims for Patent: 8,552,025

« Back to Dashboard

Summary for Patent: 8,552,025
Title:Stable methylnaltrexone preparation
Abstract: Stable pharmaceutical compositions useful for administering methylnaltrexone are described, as are methods for making the same. Kits, including these pharmaceutical compositions, also are provided.
Inventor(s): Sanghvi; Suketu P. (Kendall Park, NJ), Boyd; Thomas A. (Grandview, NY)
Assignee: Progenics Pharmaceuticals, Inc. (Tarrytown, NY)
Application Number:12/639,862
Patent Claims: 1. A stable pharmaceutical preparation comprising a solution of methylnaltrexone or a salt thereof, wherein the preparation comprises a pH between about 3.0 and about 4.0.

2. The pharmaceutical preparation of claim 1, wherein the pH is about 3.0 to about 3.5.

3. The pharmaceutical preparation of claim 1, wherein the concentration of methylnaltrexone or salt thereof ranges from 0.01 to 100 mg/ml.

4. The pharmaceutical preparation of claim 1, wherein the concentration of methylnaltrexone or salt thereof ranges from 1.0 to 50.0 mg/ml.

5. The pharmaceutical preparation of claim 1, wherein the concentration of methylnaltrexone or salt thereof is about 20 mg/ml.

6. The pharmaceutical preparation of claim 1, wherein the preparation is stable to storage for 6 months at about room temperature.

7. The pharmaceutical preparation of claim 1, wherein the preparation is stable to storage for 12 months at about room temperature.

8. The pharmaceutical preparation of claim 1, wherein the preparation is stable to storage for 24 months at about room temperature.

9. The pharmaceutical preparation of claim 1, further comprising a preservative.

10. The pharmaceutical preparation of claim 4, further comprising a preservative.

11. The pharmaceutical preparation of claim 1, further comprising an isotonicity agent.

12. The pharmaceutical preparation of claim 4, further comprising an isotonicity agent.

13. The pharmaceutical preparation of claim 1, wherein the preparation is suitable for parenteral administration.

14. The pharmaceutical preparation of claim 13, wherein the solution is provided in a vial with a septum or in a syringe.

15. The pharmaceutical preparation of claim 6, further comprising a preservative.

16. The pharmaceutical preparation of claim 6, further comprising an isotonicity agent.

17. The pharmaceutical preparation of claim 6, wherein the preparation is suitable for parenteral administration.

18. A pharmaceutical preparation comprising a solution of methylnaltrexone or a salt thereof, wherein the preparation has a pH ranging from 3.0 to 4.0, wherein the preparation is stable to storage for 6 months at about room temperature and wherein the preparation is suitable for parenteral administration.

19. The pharmaceutical preparation of claim 18, further comprising a preservative.

20. The pharmaceutical preparation of claim 18, further comprising an isotonicity agent.

21. The pharmaceutical preparation of claim 18, wherein the preparation has a pH of about 3.5.

22. The pharmaceutical preparation of claim 18, wherein the preparation has a pH of about 3.0 to about 3.5.

23. The pharmaceutical preparation of claim 1, wherein the preparation has a pH of about 3.5.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Healthtrust
Medtronic
US Department of Justice
Cerilliant
Harvard Business School
Dow
QuintilesIMS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot